Delivery of Brain-Derived Neurotrophic Factor by 3D Biocompatible Polymeric Scaffolds for Neural Tissue Engineering and Neuronal Regeneration
Perrone Donnorso, M.
Di Fabrizio, Enzo M.
KAUST DepartmentPhysical Sciences and Engineering (PSE) Division
Materials Science and Engineering Program
Biological and Environmental Sciences and Engineering (BESE) Division
Analytical Core Lab
MetadataShow full item record
AbstractBiopolymers are increasingly employed for neuroscience applications as scaffolds to drive and promote neural regrowth, thanks to their ability to mediate the upload and subsequent release of active molecules and drugs. Synthetic degradable polymers are characterized by different responses ranging from tunable distension or shrinkage to total dissolution, depending on the function they are designed for. In this paper we present a biocompatible microfabricated poly-ε-caprolactone (PCL) scaffold for primary neuron growth and maturation that has been optimized for the in vitro controlled release of brain-derived neurotrophic factor (BDNF). We demonstrate that the designed morphology confers to these devices an enhanced drug delivery capability with respect to monolithic unstructured supports. After incubation with BDNF, micropillared PCL devices progressively release the neurotrophin over 21 days in vitro. Moreover, the bioactivity of released BDNF is confirmed using primary neuronal cultures, where it mediates a consistent activation of BDNF signaling cascades, increased synaptic density, and neuronal survival. These results provide the proof-of-principle on the fabrication process of micropatterned PCL devices, which represent a promising therapeutic option to enhance neuronal regeneration after lesion and for neural tissue engineering and prosthetics.
CitationLimongi T, Rocchi A, Cesca F, Tan H, Miele E, et al. (2018) Delivery of Brain-Derived Neurotrophic Factor by 3D Biocompatible Polymeric Scaffolds for Neural Tissue Engineering and Neuronal Regeneration. Molecular Neurobiology. Available: http://dx.doi.org/10.1007/s12035-018-1022-z.
SponsorsThe work was supported by the King Abdullah University of Science and Technology start-up funding and by research grants from the European Union FP7 BNeuroscaffolds^ (grant number 604263 to FB), Compagnia di San Paolo-Italy (to FC).
- Pharmacologically active microcarriers delivering BDNF within a hydrogel: Novel strategy for human bone marrow-derived stem cells neural/neuronal differentiation guidance and therapeutic secretome enhancement.
- Authors: Kandalam S, Sindji L, Delcroix GJ, Violet F, Garric X, André EM, Schiller PC, Venier-Julienne MC, des Rieux A, Guicheux J, Montero-Menei CN
- Issue date: 2017 Feb
- Nanofibrous scaffolds releasing a small molecule BDNF-mimetic for the re-direction of endogenous neuroblast migration in the brain.
- Authors: Fon D, Zhou K, Ercole F, Fehr F, Marchesan S, Minter MR, Crack PJ, Finkelstein DI, Forsythe JS
- Issue date: 2014 Mar
- 3D presentation of a neurotrophic factor for the regulation of neural progenitor cells.
- Authors: Zhou K, Thouas G, Bernard C, Forsythe JS
- Issue date: 2014
- Three-dimensional nanofibrous scaffolds incorporating immobilized BDNF promote proliferation and differentiation of cortical neural stem cells.
- Authors: Horne MK, Nisbet DR, Forsythe JS, Parish CL
- Issue date: 2010 Jun
- Electrophoretic Deposition of Dexamethasone-Loaded Mesoporous Silica Nanoparticles onto Poly(L-Lactic Acid)/Poly(ε-Caprolactone) Composite Scaffold for Bone Tissue Engineering.
- Authors: Qiu K, Chen B, Nie W, Zhou X, Feng W, Wang W, Chen L, Mo X, Wei Y, He C
- Issue date: 2016 Feb 17